Cardio Diagnostics (CDIO) Projected to Post Earnings on Monday

Cardio Diagnostics (NASDAQ:CDIO) is projected to post its quarterly earnings results before the market opens on Monday, April 7th. Analysts expect Cardio Diagnostics to post earnings of ($0.16) per share and revenue of $0.03 million for the quarter.

Cardio Diagnostics Trading Down 7.3 %

Shares of NASDAQ:CDIO opened at $0.31 on Friday. Cardio Diagnostics has a 1 year low of $0.19 and a 1 year high of $1.77. The firm has a fifty day moving average price of $0.46 and a 200 day moving average price of $0.48.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.